Two drug makers with sometimes stormy pasts, Biovail and Valeant Pharmaceuticals International, said Monday that they had agreed to merge in a $3.2 billion deal. The merger will create a big Canadian-American player in the world of specialty pharmaceutical companies.
via nytimes.com
No comments:
Post a Comment